MAX BioPharma Announces Key Updates on its Oxysterol Therapeutics™ Development Program, Intellectual Property Portfolio and Funding Initiatives

http://www.prnewswire.com/news-releases/max-biopharma-announces-key-updates-on-its-oxysterol-therapeutics-development-program-intellectual-property-portfolio-and-funding-initiatives-300161625.htmll